Berlin - Delayed Quote EUR
Vertex Pharmaceuticals Inc (VX1.BE)
444.00
+3.95
+(0.90%)
At close: May 2 at 8:08:28 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-492,600
-492,600
3,537,300
4,129,900
2,643,500
Investing Cash Flow
-3,770,000
-3,770,000
-3,141,700
-321,100
-340,900
Financing Cash Flow
-1,494,900
-1,494,900
-562,200
-67,700
-1,478,000
End Cash Position
4,572,200
4,572,200
10,372,300
10,512,000
6,800,100
Income Tax Paid Supplemental Data
1,082,100
1,082,100
1,677,300
1,057,800
476,300
Interest Paid Supplemental Data
30,500
30,500
43,100
52,300
56,300
Capital Expenditure
-485,400
-485,400
-258,400
-204,700
-235,000
Issuance of Debt
--
--
1,800
3,500
28,300
Repayment of Debt
-33,600
-33,600
-44,900
-85,500
-47,000
Repurchase of Capital Stock
-1,582,100
-1,582,100
-653,700
-172,000
-1,561,300
Free Cash Flow
-978,000
-978,000
3,278,900
3,925,200
2,408,500
12/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HTD.SG Corcept Therapeutics Inc
64.08
+1.65%
1T3.BE Syndax Pharmaceuticals Inc
12.00
-4.00%
0OT.DU Ocular Therapeutix Inc
7.67
+4.78%
ALZCUR.ST AlzeCure Pharma AB (publ)
2.4500
+3.38%
AC6.F AlzeCure Pharma AB (publ)
0.1755
-0.85%
22UA.MU BioNTech SE
91.15
-0.16%
22UA.BE BioNTech SE
92.80
+1.98%
BNTX.VI BioNTech SE
92.25
+1.26%
NKB2.F TG Therapeutics, Inc.
39.98
+4.98%
22UA.DU BioNTech SE
92.65
+1.87%